NUZ 0.00% 19.0¢ neurizon therapeutics limited

Ann: PharmAust Completes Share Purchase Plan, page-107

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 674 Posts.
    lightbulb Created with Sketch. 129
    I would be shocked if Phase 2 didn’t at least replicate Phase 1 results.

    There is so much data indicating MPLs effect on ALS. Biggest indicators for me of successful phase 2 results are all patients are all patients on the optimal dose of 10ml per kg, and the nFL biomaker data of 3/3 patients tested indicating a reduction in neuronal damage.

    I think most if not all prior Healey arms were based on animal cell models? Whereas 11/12 phase 1 patients are alive, and 10 continuing to OLE, and presumable still going well (pending quarterly update).




    Last edited by FloatingCity: 28/07/24
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $93.42M
Open High Low Value Volume
19.0¢ 19.3¢ 19.0¢ $25.41K 133.7K

Buyers (Bids)

No. Vol. Price($)
1 5372 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 262575 3
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.